Svensk version
Home
Patients & Public
PATIENTS & PUBLIC
THERAPY AREAS
MEDICAL CONTACTS
PATIENT ORGANIZATIONS
ORDERING PRODUCTS
OUR WEBSITES
Healthcare Professionals
HEALTHCARE PROFESSIONALS
PRODUCTS BY THERAPY AREA
PRODUCTS ALPHABETICAL LIST
MEDICAL CONTACTS
ORDERING PRODUCTS
OUR AFFILIATES & HEADQUARTERS
OUR WEBSITES
PRODUCT PIPELINE
PATIENT FOCUS
DEVELOPMENT PIPELINE
PRODUCT SUPPLY
BUSINESS DEVELOPMENT
PARTNERING
Investors & Media
INVESTORS & MEDIA
INTERIM & ANNUAL REPORTS
PRESENTATIONS
WEB & AUDIO CASTS
FINANCIAL CALENDAR
SHARE INFORMATION
PRESS RELEASES & NEWS
CORPORATE GOVERNANCE
BOARD OF DIRECTORS
SENIOR MANGEMENT
IMAGE BANK
RIGHTS ISSUE
CAPITAL MARKETS SEMINAR
About us
OUR COMPANY
VISION
MISSION & VALUES
WHY FOCUS ON RARE DISEASES
CORPORATE RESPONSIBILITY
BOARD OF DIRECTORS
SENIOR MANAGEMENT
CORPORATE GOVERNANCE
CAREERS
ALL CONTACTS
CALENDAR
You are here:
Start
|
Healthcare Professionals
|
PRODUCTS ALPHABETICAL LIST
HEALTHCARE PROFESSIONALS
PRODUCTS BY THERAPY AREA
PRODUCTS ALPHABETICAL LIST
MEDICAL CONTACTS
ORDERING PRODUCTS
OUR AFFILIATES & HEADQUARTERS
OUR WEBSITES
ReFacto AF® (moroctocog alfa)
As of 15 February 2012, ReFacto® is marketed by Pfizer in the Nordic region.
Updated
2010-09-29
Print
Tip A Friend
Share this information
E-mail
Message